Category: ODD/BTA/FTA Status Region: Asia · China Company: Innovent Biologics Suzhou Co Ltd

China NMPA grants Breakthrough Designation to Innovents IBI351 for previously treated advanced colorectal carcinoma

China NMPA grants Breakthrough Designation to Innovents IBI351 for previously treated advanced colorectal carcinoma
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company, announced that the Center for Drug Evaluation (CDE) of China

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!